Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(4.05)
# 483
Out of 5,182 analysts
352
Total ratings
42.66%
Success rate
15.46%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASMB Assembly Biosciences | Assumes: Buy | $50 | $26.82 | +86.43% | 1 | Aug 18, 2025 | |
| ALT Altimmune | Reiterates: Buy | $12 | $2.60 | +361.54% | 19 | Aug 13, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $500 → $570 | $309.49 | +84.17% | 27 | Aug 7, 2025 | |
| CMPS COMPASS Pathways | Maintains: Buy | $45 → $40 | $9.06 | +341.50% | 17 | Aug 4, 2025 | |
| ATAI AtaiBeckley | Maintains: Buy | $10 → $15 | $4.16 | +260.58% | 20 | Jul 30, 2025 | |
| ANRO Alto Neuroscience | Reiterates: Buy | $10 | $25.66 | -61.03% | 2 | Jun 26, 2025 | |
| IVVD Invivyd | Reiterates: Buy | $5 | $1.40 | +257.14% | 19 | Jun 26, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.12 | +8,289.26% | 26 | Jun 24, 2025 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $7.31 | +925.99% | 24 | Jun 13, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $27.91 | +258.29% | 21 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $19.95 | +250.88% | 15 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.88 | +468.18% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $7.16 | +737.99% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $73.48 | +8.87% | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $20.53 | +94.84% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $3.73 | +704.29% | 10 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $31.26 | +123.93% | 6 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $30.33 | +163.77% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $10 | $1.80 | +455.56% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.37 | +2,618.87% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $10.22 | +976.85% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $87.95 | -3.35% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $12.05 | +464.32% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $65.87 | +416.17% | 1 | Aug 18, 2021 |
Assembly Biosciences
Aug 18, 2025
Assumes: Buy
Price Target: $50
Current: $26.82
Upside: +86.43%
Altimmune
Aug 13, 2025
Reiterates: Buy
Price Target: $12
Current: $2.60
Upside: +361.54%
Alnylam Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $500 → $570
Current: $309.49
Upside: +84.17%
COMPASS Pathways
Aug 4, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $9.06
Upside: +341.50%
AtaiBeckley
Jul 30, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $4.16
Upside: +260.58%
Alto Neuroscience
Jun 26, 2025
Reiterates: Buy
Price Target: $10
Current: $25.66
Upside: -61.03%
Invivyd
Jun 26, 2025
Reiterates: Buy
Price Target: $5
Current: $1.40
Upside: +257.14%
Sangamo Therapeutics
Jun 24, 2025
Reiterates: Buy
Price Target: $10
Current: $0.12
Upside: +8,289.26%
Silence Therapeutics
Jun 13, 2025
Reiterates: Buy
Price Target: $75
Current: $7.31
Upside: +925.99%
Immunocore Holdings
Jun 2, 2025
Reiterates: Buy
Price Target: $100
Current: $27.91
Upside: +258.29%
May 29, 2025
Reiterates: Buy
Price Target: $70
Current: $19.95
Upside: +250.88%
May 21, 2025
Reiterates: Buy
Price Target: $5
Current: $0.88
Upside: +468.18%
May 21, 2025
Reiterates: Buy
Price Target: $60
Current: $7.16
Upside: +737.99%
May 20, 2025
Reiterates: Buy
Price Target: $80
Current: $73.48
Upside: +8.87%
May 9, 2025
Reiterates: Buy
Price Target: $40
Current: $20.53
Upside: +94.84%
Apr 8, 2025
Reiterates: Buy
Price Target: $30
Current: $3.73
Upside: +704.29%
Apr 8, 2025
Reiterates: Buy
Price Target: $70
Current: $31.26
Upside: +123.93%
Apr 7, 2025
Reiterates: Buy
Price Target: $80
Current: $30.33
Upside: +163.77%
Apr 1, 2025
Maintains: Buy
Price Target: $25 → $10
Current: $1.80
Upside: +455.56%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $0.37
Upside: +2,618.87%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $10.22
Upside: +976.85%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $87.95
Upside: -3.35%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $12.05
Upside: +464.32%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $65.87
Upside: +416.17%